Lisa Rydén
181 – 190 of 216
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
AIB1 is a predictive factor for tamoxifen response in premenopausal women.
- Contribution to journal › Article
-
Mark
Does Analysis of Biomarkers in Tumor Cells in Lymph Node Metastases Give Additional Prognostic Information in Primary Breast Cancer?
- Contribution to journal › Article
-
Mark
Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
- Contribution to journal › Article
-
Mark
Modeling Prognostic Markers in Breast Cancer — Are We Using Them the Optimal Way?
- Contribution to journal › Published meeting abstract
-
Mark
Prediction of outcome after diagnosis of metachronous contralateral breast cancer
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
Vascular endothelial growth factor receptor 2 is a significant negative prognostic biomarker in triple-negative breast cancer: results from a controlled randomised trial of premenopausal breast cancer
- Contribution to journal › Published meeting abstract
-
Mark
Reproducibility of human epidermal growth factor receptor 2 analysis in primary breast cancer - A national survey performed at pathology departments in Sweden.
- Contribution to journal › Article
-
Mark
Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial.
- Contribution to journal › Article
-
Mark
Erythropoietin Receptor Expression and Correlation to Tamoxifen Response and Prognosis in Breast Cancer.
- Contribution to journal › Article
-
Mark
Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer.
(2009) In Modern Pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 22. p.1564-1574
- Contribution to journal › Article
